Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design
about
Genotoxicity and carcinogenic potential of carbon nanomaterialsCell Death Conversion under Hypoxic Condition in Tumor Development and TherapyNext generation sequencing applications for breast cancer research.Carcinogenic potential of high aspect ratio carbon nanomaterialsPathological bases for a robust application of cancer molecular classificationInsight on Mutation-Induced Resistance from Molecular Dynamics Simulations of the Native and Mutated CSF-1R and KITEvaluation of serum lysyl oxidase as a blood test for colorectal cancer.Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS).Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment.Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome SequencingAssociation of APE1 Gene Asp148Glu Variant with Digestive Cancer: A Meta-Analysis.The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancerMigration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver LesionsIsolation and Characterization of Single Cells from Zebrafish Embryos.Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse modelTrAp: a tree approach for fingerprinting subclonal tumor composition.Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells.Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.Therapy resistance mechanisms in Ewing's sarcoma family tumors.Cancer biomarker discovery: current status and future perspectives.Low-fidelity compensatory backup alternative DNA repair pathways may unify current carcinogenesis theories.Gene expression profiling for targeted cancer treatment.Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.Murine melanoma cells incomplete reprogramming using non-viral vector.Pre-metastatic niches: organ-specific homes for metastases.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses.Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer.Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.Cell-ECM Interactions in Tumor Invasion.Intratumoral phenotypic heterogeneity as an encourager of cancer invasion.Cellular imaging and texture analysis distinguish differences in cellular dynamics in mouse brain tumors.Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.Soft nanomaterial-based targeting polymersomes for near-infrared fluorescence multispectral in vivo imaging.Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.Expression of miR-146a in patients with ovarian cancer and its clinical significance.Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer
P2860
Q26322763-668F30BA-5F1B-44AE-B685-148D5411B260Q26778008-C5C90D6A-D046-4AB3-9C57-DBFA6CB4E6CBQ27690994-3E08EF72-D5A0-4CBF-8DAE-DDE8E843C6ECQ27908487-E8152A13-AA90-4449-93CC-D571574C3080Q28082201-343FFB93-C9EE-4F2E-857D-FD8BDB10A0F6Q28553167-1C684650-EFF9-40F9-89FD-1BD27B325443Q34540364-19714C0F-0FDA-4C62-B31D-3E1CE09AD58AQ34859119-6486630E-38D3-4929-A31C-AAC1D577B38FQ35097661-1CA039C1-99D1-46A9-9CBF-AF78F71629A9Q35135634-148B5FDD-C61E-44CF-8179-CBC842C51362Q35672428-FE8AEA7F-5195-4A84-B4B5-63612A11E1AAQ35994268-1C0F473C-9F86-450F-AEBE-8A938BA38227Q36236130-CEA578D7-4FF8-4AC4-8D29-D2EEE0E24EBFQ36545873-9EC03844-7797-4D9D-902E-DD6967F35484Q36556526-410AA45A-E5BE-4D6C-9C6F-AB6F2F79F8C3Q36790767-2EC22012-7601-478D-B7E5-8C2AADBFD767Q37180312-CADADA79-1039-4D79-BA5C-8A2F9B932115Q37197845-986CFF9A-E3BF-45B6-A651-16E61492E5D6Q37565183-6B96F28D-0B88-4338-B456-579189607B58Q37618755-54055104-A798-40F3-8A5C-42ABDE34CF16Q38182423-2109D5C8-C508-405D-9CC8-E95F1854D287Q38187679-3CA2EB8A-6AE3-40F0-B16C-766AB1CC37DCQ38221690-C6FECF37-78F0-4519-B906-192755540E2BQ38259249-DB18C230-80EB-4D07-83BE-60F210810A51Q38695225-03EF774A-C4B6-4D0E-9C61-10FD918DE5F0Q38700249-CD080A1E-7A7C-4FEF-806A-D1E0F9A9DBE7Q38743711-1DBB6F0E-73E3-490A-B57D-07C3C197583DQ38856277-4B2BACDC-EDEB-4F26-9662-9E935A731F50Q38881952-304E5A82-5117-48D5-B30D-9A450D5E7084Q38892088-F469E73F-28B5-4408-849C-4F51ABD115A7Q38951812-AB599E71-2060-44D5-BD8E-7ADC44192A0BQ38980083-045D1B1A-9C46-4111-AFB9-6C68FF4947D3Q38993432-B00E85E0-7C27-4F22-97D4-5B79D04019C5Q39153862-22283E18-256B-4E0A-81CE-FCED886CEE5FQ39232228-1F7FDC4A-0D79-4732-AA16-D302E3507801Q39258724-899E2720-187A-4EC9-9068-77D1241859D3Q39294808-6792D11B-1D40-40E3-9E01-6CBF46AC3F24Q41618429-11B63EA0-BF67-45A4-BEF3-9451413E9553Q41872668-1A09DBF9-9265-4AAE-BAF8-B1238F9E36BEQ41912578-A56878B2-5011-4B94-A7E6-696F70CE0D9D
P2860
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@ast
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@en
type
label
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@ast
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@en
prefLabel
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@ast
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@en
P2860
P921
P356
P1476
Tumor heterogeneity: mechanism ...... ion of molecular marker design
@en
P2093
Salvador J Diaz-Cano
P2860
P304
P356
10.3390/IJMS13021951
P407
P5008
P577
2012-02-13T00:00:00Z